Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease
The capacity of stem and progenitor cells to stimulate cardiac regeneration has been studied for almost 20 years, with very promising preclinical data and mixed clinical results. Several cell types have been studied, identified by their cell surface markers, differentiation capacity and their secret...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052612/ https://www.ncbi.nlm.nih.gov/pubmed/29665255 http://dx.doi.org/10.1002/sctm.17-0210 |